Aceragen (ACGN)

Aceragen (ACGN) Stock Price & Analysis


ACGN Stock Chart & Stats

Day’s Range$0.38 - $0.441101
52-Week Range― - ―
Previous Close$0.44
Average Volume (3M)N/A
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Aceragen’s price range in the past 12 months?
Currently, no data Available
What is Aceragen’s market cap?
Currently, no data Available
When is Aceragen’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Aceragen’s earnings last quarter?
Currently, no data Available
Is Aceragen overvalued?
According to Wall Street analysts Aceragen’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does Aceragen pay dividends?
    Aceragen does not currently pay dividends.
    What is Aceragen’s EPS estimate?
    Aceragen’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Aceragen have?
    Currently, no data Available
    What happened to Aceragen’s price movement after its last earnings report?
    Currently, no data Available
    Which hedge fund is a major shareholder of Aceragen?
    Currently, no hedge funds are holding shares in ACGN


    Aceragen Stock Smart Score

    This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
    Learn more about TipRanks Smart Score

    Company Description


    Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Cambridge, MA.


    Top 5 ETFs holding ACGN

    Market Value
    Smart Score
    Vanguard Total Stock Market ETF
    Up to five ETFs with an Outperform Smart Score that hold ACGN. The ETFs are listed according to market value of ACGN within the ETF

    Forecast EPS vs Actual EPS

    Currently, no data available
    Please return soon. This page is being updated.

    Similar Stocks
    Price & Change
    Forte Biosciences
    RegeneRx Biopharmaceuticals
    bioAffinity Technologies, Inc.
    Neoleukin Therapeutics
    AgeX Therapeutics

    Popular Stocks

    What's Included in PREMIUM?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis